sur DocMorris AG (isin : CH0042615283)
DocMorris AG Secures gematik Approval for Digital E-Prescription Service via Health Card
DocMorris has announced the successful completion of its product and provider approval process for its digital e-prescription redemption service, eHealth-CardLink, approved by gematik. This service facilitates the redemption of e-prescriptions via the electronic health card (eGK), marking a significant milestone in digital healthcare in Germany. The service is now available through the DocMorris app, offering users a streamlined and secure process for obtaining their prescribed medications.
Walter Hess, CEO of DocMorris, highlighted the importance of e-prescriptions in the modern healthcare ecosystem, with approximately 70% of all prescriptions in Germany now issued electronically. The new eHealth-CardLink solution is expected to enhance patient experience significantly by offering a simple, fully digitalized way to redeem prescriptions. This development underscores DocMorris's commitment to providing accessible and reliable healthcare solutions through its app.
The approval by gematik confirms the eHealth-CardLink's compliance with high security and data protection standards, ensuring that patient data remains secure throughout the process. Additionally, the service promises to improve the efficiency and convenience of online pharmacies, with next-day delivery for e-prescriptions redeemed through the app. The integration of this service is poised to benefit not just patients but also facilitate better care for chronically ill individuals through features like follow-up prescription subscriptions.
R. H.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de DocMorris AG